Laidlaw Stock Recommendations and Price Targets

This is a list of recent ratings by Laidlaw.

DateCompany NameActionCurrent
Price
Price
Target
RatingImpact on
Share Price
7/29/2024
ABVX
ABIVAX Société Anonyme
Initiated Coverage$9.00 $48.00BuyLow
7/23/2024
MEIP
MEI Pharma
Downgrade$3.00Buy ➝ HoldLow
6/13/2024
AFMD
Affimed
Boost Price Target$2.00$15.00 ➝ $25.00BuyLow
5/28/2024
PHGE
BiomX
Initiated Coverage$1.00 $25.00BuyN/A
3/18/2024
INAB
IN8bio
Initiated Coverage$0.00 $7.50BuyLow
12/22/2023
CING
Cingulate
Downgrade$4.00Buy ➝ HoldLow
12/13/2023
EVFM
Evofem Biosciences
Reiterated Rating$0.00Buy ➝ HoldLow
8/28/2023
SILO
Silo Pharma
Initiated Coverage$1.00 $10.00BuyLow
8/15/2023
TCRT
Alaunos Therapeutics
Downgrade$2.00Buy ➝ HoldLow
6/5/2023
BLPH
Bellerophon Therapeutics
Downgrade$0.00Buy ➝ HoldLow
5/9/2023
BLPH
Bellerophon Therapeutics
Initiated Coverage$0.00BuyLow
9/6/2022
NLSP
NLS Pharmaceutics
Initiated Coverage$2.00 $6.00BuyLow
6/2/2022
EVFM
Evofem Biosciences
Initiated Coverage$0.00 $437.50BuyHigh
1/20/2022
CING
Cingulate
Initiated Coverage$4.00 $170.00BuyHigh